chevron_leftBack
As of 20 June 2026, Han.biomedical Inc. has a market cap of $21.58M USD, ranking #36600 globally and #2220 in Taiwan.
It ranks #3292 in the Healthcare sector, and #641 in the Biotechnology industry.
Key Stats
Market Cap
$21.58MUSD
682.47M TWD
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Biotechnology
CEO
Changhui Chen
open_in_new
Website
hanbiomedical.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -1.4% | 0.8% | 12% | -7.3% | -12% | -12% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
6999
瀚醫生技股份有限公司
ISIN: TW0006999006
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
31.50 TWD |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Han.biomedical Inc.
Han.biomedical Inc. develops structured biomaterials for tissue regeneration in Taiwan. It offers BarriGel adhesion prevention gel; HANBIO patient lubricant; HANCARE collagen matrix; HANBIO gauze; and LEOFOR hyaluronic acid solution. The company is based in New Taipei City, Taiwan.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
TWSE: 6919
|
$5.46B
25K%
172.76B TWD
|
-
|
|
TWSE: 6949
|
$1.61B
7K%
50.93B TWD
|
-
|
|
TPEX: 6696
|
$1.08B
5K%
34.04B TWD
|
-
|
|
TWSE: 7827
|
$726.25M
3K%
22.97B TWD
|
-
|
|
|
TPEX: 7827
|
$600.25M
3K%
18.98B TWD
|
-
|
|
TPEX: 06891
|
$571.26M
3K%
18.06B TWD
|
-
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NASDAQ: AMGN
|
$182.42B
845K%
|
23.9
|
|
NASDAQ: GILD
|
$159.92B
741K%
|
19.0
|
|
EBR: ARGX
|
$47.43B
220K%
41.39B EUR
|
39.9
|
|
KRX: 207940
|
$44.23B
205K%
68.19T KRW
|
35.5
|
|
ASX: CSL
|
$42.27B
196K%
60.27B AUD
|
29.3
|
|
SIX: LONN
|
$41.88B
194K%
33.71B CHF
|
37.2
|
chevron_leftBack